Camlin Fine Sciences Ltd

Camlin Fine Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Camlin Fine Sciences Ltd

₹ 154 -3.25%
21 Nov - close price
camlinfs.com BSE: 532834 NSE: CAMLINFINE
About

Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.

Key Points

Business Verticals

Website BSE NSE
  • Market Cap ₹ 2,904 Cr.
  • Current Price ₹ 154
  • High / Low ₹ 335 / 110
  • Stock P/E 181
  • Book Value ₹ 47.3
  • Dividend Yield 0.00 %
  • ROCE 11.0 %
  • ROE -15.0 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 3.26 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 9.70% over past five years.
  • Company has a low return on equity of -6.69% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
483 388 427 420 406 386 377 381 417 431 437 424 460
428 338 383 381 381 363 345 352 366 375 378 405 427
Operating Profit 55 50 44 39 25 23 31 29 52 56 59 19 33
OPM % 11% 13% 10% 9% 6% 6% 8% 8% 12% 13% 14% 4% 7%
3 10 -8 6 2 2 -96 -15 -151 -8 -17 3 -4
Interest 18 12 10 10 20 14 16 23 26 34 16 16 19
Depreciation 14 16 18 19 19 21 13 15 17 14 18 17 19
Profit before tax 26 32 8 16 -12 -10 -94 -23 -142 -0 8 -11 -9
Tax % 61% 28% 59% 25% 72% 47% -13% 48% -18% 2,164% 99% -0% 65%
10 23 3 12 -21 -14 -82 -35 -116 -7 0 -11 -15
EPS in Rs 0.74 1.36 0.52 0.83 -1.03 -0.63 -4.11 -1.81 -5.33 -0.22 -0.04 -0.53 -0.76
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
509 558 489 534 721 892 1,049 1,187 1,412 1,682 1,454 1,667 1,752
446 474 397 502 705 819 914 1,000 1,254 1,468 1,284 1,447 1,584
Operating Profit 63 84 92 32 16 73 135 187 158 213 170 220 167
OPM % 12% 15% 19% 6% 2% 8% 13% 16% 11% 13% 12% 13% 10%
9 9 -1 14 12 14 3 5 33 -4 -142 -203 -26
Interest 25 24 24 31 32 41 48 42 41 66 70 111 85
Depreciation 12 16 17 22 27 29 33 44 56 63 56 64 69
Profit before tax 35 53 50 -6 -31 17 58 105 94 80 -99 -158 -12
Tax % 18% -4% 28% -26% -22% 82% 49% 38% 36% 50% 6% 0%
29 55 36 -4 -24 3 30 65 60 40 -105 -158 -33
EPS in Rs 2.71 5.11 3.30 -0.96 -2.18 0.04 2.23 3.56 3.45 2.96 -4.94 -7.40 -1.55
Dividend Payout % 12% 8% 12% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 12%
5 Years: 10%
3 Years: 6%
TTM: 12%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -37%
Stock Price CAGR
10 Years: 4%
5 Years: 9%
3 Years: -1%
1 Year: 31%
Return on Equity
10 Years: -1%
5 Years: -2%
3 Years: -7%
Last Year: -15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 9 10 10 10 12 12 12 13 16 16 17 19 19
Reserves 84 125 167 202 359 359 391 631 732 804 848 883 871
150 160 180 331 373 461 539 550 646 801 683 681 672
126 131 123 126 273 255 290 282 396 425 424 454 476
Total Liabilities 369 426 479 669 1,016 1,087 1,232 1,475 1,790 2,045 1,972 2,037 2,037
83 106 140 201 278 272 306 584 601 858 816 704 700
CWIP 22 3 25 8 14 59 179 24 215 43 46 10 15
Investments 1 1 1 19 115 11 7 7 7 8 8 61 69
262 316 313 442 609 745 740 861 966 1,136 1,102 1,262 1,253
Total Assets 369 426 479 669 1,016 1,087 1,232 1,475 1,790 2,045 1,972 2,037 2,037

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
27 46 72 -9 -15 -9 86 117 145 51 139 27
-32 -26 -66 -70 -149 -2 -90 -133 -249 -125 -66 -75
-6 -15 -7 91 182 26 3 39 136 60 -86 72
Net Cash Flow -12 4 -1 13 18 15 -1 23 32 -14 -13 24

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 73 74 56 99 104 86 88 83 77 66 72 72
Inventory Days 145 184 311 277 207 219 204 200 178 255 256 233
Days Payable 132 144 171 110 154 127 119 99 112 129 154 162
Cash Conversion Cycle 85 114 196 266 157 178 173 184 143 192 174 143
Working Capital Days -4 12 1 -6 19 43 22 55 40 42 51 35
ROCE % 28% 28% 24% 5% 0% 7% 11% 13% 10% 10% 8% 11%

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
17.64% 17.64% 16.52% 48.03% 48.03% 48.04% 48.03% 48.03% 48.03% 49.09% 49.09% 49.08%
10.94% 10.18% 10.11% 1.61% 0.99% 1.69% 1.01% 0.81% 0.76% 1.47% 2.88% 2.11%
12.53% 12.32% 9.31% 3.89% 3.75% 4.55% 4.88% 4.23% 3.38% 3.83% 4.14% 5.48%
0.00% 0.03% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
58.88% 59.82% 64.01% 46.46% 47.22% 45.73% 46.07% 46.93% 47.83% 45.61% 43.88% 43.33%
No. of Shareholders 54,19752,92152,27857,09862,09858,16562,68767,75061,89358,11159,53857,661

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls